Liposome opsonization

Journal of Liposome Research

Volumn 15, Issue 1-2, 2005, Pages 109-139

  Yan, Xuedong ^a   Scherphof, Gerrit L ^a   Kamps, Jan A A M ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Dysopsonization; Liposomes; Opsonins; Poly(ethylene glycol)

Indexed keywords

ALBUMIN; ALPHA 2 MACROGLOBULIN; AMYLOID P COMPONENT; APOLIPOPROTEIN; BETA2 GLYCOPROTEIN 1; C REACTIVE PROTEIN; CELL SURFACE RECEPTOR; FIBRONECTIN; LIPOSOME; MACROGOL; MANNOSE BINDING PROTEIN; MONOCLONAL ANTIBODY; OPSONIN; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR BI;

COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIVER PERFUSION; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HUMANS; LIPOSOMES; OPSONIN PROTEINS; PHOSPHATIDYLSERINES; POLYETHYLENE GLYCOLS; RECEPTORS, CELL SURFACE;

EID: 22144444549     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.1081/LPR-64971     Document Type: Review

References (196)

1. Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., Krieger, M. (1996). Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271(5248):518-520.
2. Acton, S. L., Scherer, P. E., Lodish, H. F., Krieger, M. (1994). Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 269(33):21003-21009.
3. Ahl, P. L., Bhatia, S. K., Meers, P., Roberts, P., Stevens, R., Dause, R., Perkins, W. R., Janoff, A. S. (1997). Enhancement of the in vivo circulation lifetime of L-alpha-distearoylphosphatidylcholine liposomes: importance of liposomal aggregation versus complement opsonization. Biochim. Biophys. Acta 1329(2):370-382.
4. Alberts, D. S., Garcia, D. J. (1997). Safety aspects of pegylated liposomal doxorubicin in patients with cancer. Drugs 54 suppl 4:30-35.
5. Allen, C., Dos Santos, N., Gallagher, R., Chiu, G. N., Shu, Y., Li, W. M., Johnstone, S. A., Janoff, A. S., Mayer, L. D., Webb, M. S., Bally, M. B. (2002). Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol). Biosci. Rep. 22(2):225-250.
6. Allen, T. M., Chonn, A. (1987). Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 223(1):42-46.
7. Allen, T. M., Cullis, P. R. (2004). Drug delivery systems: entering the mainstream. Science 303(5665):1818-1822.
8. Allen, T. M., Williamson, P., Schlegel, R. A. (1988). Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface. Proc. Natl. Acad. Sci. U. S. A. 85(21):8067-8071.
9. Allen, T. M., Hansen, C., Martin, F., Redemann, C., Yau-Young, A. (1991). Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1066(1):29-36.
10. Alving, C. R., Swartz, G. M. Jr. (1991). Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atherosclerosis and autoimmunity. Crit. Rev. Immunol. 10(5):441-453.
11. Alving, C. R., Urban, K. A., Richards, R. L. (1980). Influence of temperature on complement-dependent immune damage to liposomes. Biochim. Biophys. Acta 600(1):117-125.
12. Aragnol, D., Leserman, L. D. (1986). Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo. Proc. Natl. Acad. Sci. U. S. A. 83(8):2699-2703.
13. Azegami, S., Tsuboi, A., Izumi, T., Hirata, M., Dubin, P. L., Wang, B., Kokufuta, E. (1999). Formation of an intrapolymer complex from human plasma. Langmuir 15:940-947.
14. Balasubramanian, K., Schroit, A. J. (1998). Characterization of phosphatidylserine-dependent beta2-glycoprotein I macrophage interactions. Implications for apoptotic cell clearance by phagocytes. J. Biol. Chem. 273(44):29272-29277.
15. Balasubramanian, K., Chandra, J., Schroit, A. J. (1997). Immune clearance of phosphatidylserine-expressing cells by phagocytes. The role of beta2-glycoprotein I in macrophage recognition. J. Biol. Chem. 272(49):31113-31117.
16. Bangham, A. D. (1993). Liposomes: the Babraham connection. Chem. Phys. Lipids 64(1-3):275-285.
17. Barna, B. P., Deodhar, S. D., Gautam, S., Yen-Lieberman, B., Roberts, D. (1984). Macrophage activation and generation of tumoricidal activity by liposome-associated human C-reactive protein. Cancer Res. 44(1):305-310.
18. Bendas, G., Rothe, U., Scherphof, G. L., Kamps, J. A. A. M. (2003). The influence of repeated injections on pharmacokinetics and biodistribution of different types of sterically stabilized immunoliposomes. Biochim. Biophys. Acta 1609(1):63-70.
19. Bisgaier, C. L., Siebenkas, M. V., Williams, K. J. (1989). Effects of apolipoproteins A-IV and A-I on the uptake of phospholipid liposomes by hepatocytes. J. Biol. Chem. 264(2):862-866.
20. Black, C. D., Gregoriadis, G. (1976). Interaction of liposomes with blood plasma proteins. Biochem. Soc. Trans. 4(2):253-256.
21. Blume, G., Cevc, G. (1990). Liposomes for the sustained drug release in vivo. Biochim. Biophys. Acta 1029(1):91-97.
22. Bonte, F., Juliano, R. L. (1986). Interactions of liposomes with serum proteins. Chem. Phys. Lipids 40(2-4):359-372.
23. Bonte, F., Hsu, M. J., Papp, A., Wu, K., Regen, S. L., Juliano, R. L. (1987). Interactions of polymerizable phosphatidylcholine vesicles with blood components: relevance to biocompatibility. Biochim. Biophys. Acta 900(1):1-9.
24. Bourne, B., de Groot, P. G., van del Elsen, J. M., Ravelli, R. B., Scheuten, A., Simmerlink, M. J., Derksen, R. H., Kroon, J., Gros, P. (1999). Adhesion mechanism of human beta(2)-glycoprotein 1 to phospholipids based on its cyrstal structure. EMBO J. 18(19):5166-5174.
25. Bradley, A. J., Devine, D. V., Ansell, S. M., Janzen, J., Brooks, D. E. (1998). Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids. Arch. Biochem. Biophys. 357(2):185-194.
26. Bradley, A. J., Brooks, D. E., Norris-Jones, R., Devine, D. V. (1999a). Clq binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14-26 of the human ClqA chain in a sequence independent manner. Biochim. Biophys. Acta 1418(1):19-30.
27. Bradley, A. J., Maurer-Spurej, E., Brooks, D. E., Devine, D. V. (1999b). Unusual electrostatic effects on binding of Clq to anionic liposomes: role of anionic phospholipid domains and their line tension. Biochemistry 38(25):8112-8123.
28. Brown, M. S., Goldstein, J. L. (1986). A receptor-mediated pathway for cholesterol homeostasis. Science 232(4746):34-47.
29. Brown, M. S., Goldstein, J. L. (1983). Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52:223-261.
30. Chanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N. M., Alving, C. R., Muggia, F. M. (2003). Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Ann. Oncol. 14(9):1430-1437.
31. Chiu, G. N., Bally, M. B., Mayer, L. D. (2001). Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol). Biochim. Biophys. Acta 1510(1-2):56-69.
32. Chonn, A., Cullis, P. R., Devine, D. V. (1991a). The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J. Immunol. 146(12):4234-4241.
33. Chonn, A., Semple, S. C., Cullis, P. R. (1991b). Separation of large unilamellar liposomes from blood components by a spin column procedure: towards identifying plasma proteins which mediate liposome clearance in vivo. Biochim. Biophys. Acta 1070(1):215-222.
34. Chonn, A., Semple, S. C., Cullis, P. R. (1992). Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J. Biol. Chem. 267(26):18759-18765.
35. Chonn, A., Semple, S. C., Cullis, P. R. (1995). Beta 2 glycoprotein 1 is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of "non-self" particles. J. Biol. Chem. 270(43):25845-25849.
36. Claus, D. R., Siegel, J., Petras, K., Osmand, A. P., Gewurz, H. (1977). Interactions of C-reactive protein with the first component of human complement. J. Immunol. 119(1):187-192.
37. Cullis, P. R., Chonn, A., Semple, S. C. (1998). Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo. Adv. Drug Deliv. Rev. 32(1-2):3-17.
38. Dams, E. T., Laverman, P., Oyen, W. J., Storm, G., Scherphof, G. L., Der Meer, J. W., Corstens, F. H., Boerman, O. C. (2000). Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J. Pharmacol. Exp. Ther. 292(3):1071-1079.
39. Debs, R. J., Heath, T. D., Papahadjopoulos, D. (1987). Targeting of anti-Thy 1.1 monoclonal antibody conjugated liposomes in Thy 1.1 mice after intravenous administration. Biochim. Biophys. Acta 901(2):183-190.
40. DeLozier, J. A., Parks, J. S., Shelness, G. S. (2001). Vesicle-binding properties of wild-type and cysteine mutant forms of alpha(1) domain of apolipoprotein B. J. Lipid Res. 42(3):399-406.
41. de Marie, S. (1996). Liposomal and lipid-based formulations of amphotericin B. Leukemia 10 suppl 2:s93-s96.
42. Derksen, J. T., Morselt, H. W., Kalicharan, D., Hulstaert, C. E., Scherphof, G. L. (1987). Interaction of immunoglobulin-coupled liposomes with rat liver macrophages in vitro. Exp. Cell. Res. 168(1):105-115.
43. Derksen, J. T., Morselt, H. W., Scherphof, G. L. (1988). Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages. Biochim. Biophys. Acta 971(2):127-136.
44. Devine, D. V., Wong, K., Serrano, K., Chonn, A., Cullis, P. R. (1994). Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim. Biophys. Acta 1191(1):43-51.
45. Devine, D. V., Marjan, J. M. (1997). The role of immunoproteins in the survival of liposomes in the circulation. Crit. Rev. Ther. Drug Carr. Syst. 14(2):105-131.
46. Diederichs, J. E. (1996). Plasma protein adsorption patterns on liposomes: establishment of analytical procedure. Electrophoresis 17(3):607-611.
47. Du, H., Chandaroy, P., Hui, S. W. (1997). Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion. Biochim. Biophys. Acta 1326(2):236-248.
48. Efremova, N. V., Bondurant, B., O'Brien, D. F., Leckband, D. E. (2000). Measurements of interbilayer forces and protein adsorption on uncharged lipid bilayers displaying poly(ethylene glycol) chains. Biochemistry 39(12):3441-3451.
49. Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L., Henson, P. M. (1992). Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148(7):2207-2216.
50. Fadok, V. A., Bratton, D. L., Rose, D. M., Pearson, A., Ezekewitz, R. A., Henson, P. M. (2000). A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405(6782):85-90.
51. Febbraio, M., Hajjar, D. P., Silverstein, R. L. (2001). CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108(6):785-791.
52. Ferdous, A. J., Ishida, T., Shinohara, M., Harashima, H., Kiwada, H. (1996). Size-dependent release of carboxyfluorescein from cetylmannoside- modified liposomes in human plasma. Biopharm. Drug Dispos. 17(2):145-154.
53. Fujiwara, M., Baldeschwieler, J. D., Grubbs, R. H. (1996). Receptor-mediated endocytosis of poly(acrylic acid)-conjugated liposomes by macrophages. Biochim. Biophys. Acta 1278(1):59-67.
54. Fukasawa, M., Adachi, H., Hirota, K., Tsujimoto, M., Arai, H., Inoue, K. (1996). SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells. Exp. Cell Res. 222(1):246-250.
55. Gabizon, A., Papahadjopoulos, D. (1988). Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. U. S. A. 85(18):6949-6953.
56. Gabizon, A. A., Barenholz, Y., Bialer, M. (1993). Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. Pharm. Res. 10(5):703-708.
57. Gharavi, A. E., Harris, E. N., Asherson, R. A., Hughes, G. R. (1987). Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann. Rheum. Dis. 46(1):1-6.
58. Cough, P. J., Gordon, S. (2000). The role of scavenger receptors in the innate immune system. Microbes Infect. 2(3):305-311.
59. Gregoriadis, G., Ryman, B. E. (1971). Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Biochem. J. 124(5):58P.
60. Guo, L. S., Hamilton, R. L., Goerke, J., Weinstein, J. N., Havel, R. J. (1980). Interaction of unilamellar liposomes with serum lipoproteins and apolipoproteins. J. Lipid Res. 21(8):993-1003.
61. Harashima, H., Sakata, K., Kiwada, H. (1993). Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes. Pharm. Res. 10(4):606-610.
62. Harashima, H., Sakata, K., Funato, K., Kiwada, H. (1994). Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharm. Res. 11(3):402-406.
63. Harashima, H., Huong, T. M., Ishida, T., Manabe, Y., Matsuo, H., Kiwada, H. (1996). Synergistic effect between size and cholesterol content in the enhanced hepatic uptake clearance of liposomes through complement activation in rats. Pharm. Res. 13(11):1704-1709.
64. Harper, P. A., Juliano, R. L. (1980). Isolation and characterization of Chinese hamster ovary cell variants defective in adhesion to fibronectin-coated collagen. J. Cell. Biol. 87(3 Pt 1):755-763.
65. Harvie, P., Desormeaux, A., Bergeron, M. C., Tremblay, M., Beauchamp, D., Poulin, L., Bergeron, M. G. (1996). Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2′,3′-dideoxyinosine. Antimicrob. Agents Chemother. 40(1):225-229.
66. Harris, E. N., Gharavi, A. E., Boey, M. L., Patel, B. M., Kworth-Young, C. G., Loizou, S., Hughes, G. R. (1983). Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2(8361):1211-1214.
67. Hasselbacher, P., Hahn, J. L. (1980). Activation of the alternative pathway of complement by microcrystalline cholesterol. Atherosclerosis 37(2):239-245.
68. Haxby, J. A., Kinsky, C. B., Kinsky, S. C. (1968). Immune response of a liposomal model membrane. Proc. Natl. Acad. Sci. U. S. A. 61(1):300-307.
69. Haxby, J. A., Gotze, O., Muller-Eberhard, H. J., Kinsky, S. C. (1969). Release of trapped marker from liposomes by the action of purified complement components. Proc. Natl. Acad. Sci. U. S. A. 64(1):290-295.
70. Hernandez-Caselles, T., Villalain, J., Gomez-Fernandez, J. C. (1993). Influence of liposome charge and composition on their interaction with human blood serum proteins. Mol. Cell. Biochem. 120(2):119-126.
71. Holness, C. L., Simmons, D. L. (1993). Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81(6):1607-1613.
72. Hsu, M. J., Juliano, R. L. (1982). Interactions of liposomes with the reticuloendothelial system. II: nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages. Biochim. Biophys. Acta 720(4):411-419.
73. Hunt, J., Krilis, S. (1994). The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies. J. Immunol. 152(2):653-659.
74. Huong, T. M., Ishida, T., Harashima, H., Kiwada, H. (2001). The complement system enhances the clearance of phosphatidylserine (PS)-liposomes in rat and guinea pig. Int. J. Pharm. 215(1-2):197-205.
75. Ishida, T., Kojima, H., Harashima, H., Kiwada, H. (2000). Biodistribution of liposomes and C3 fragments associated with liposomes: evaluation of their relationship. Int. J. Pharm. 205(1-2):183-193.
76. Ishida, T., Yasukawa, K., Kojima, H., Harashima, H., Kiwada, H. (2001). Effect of cholesterol content in activation of the classical versus the alternative pathway of rat complement system induced by hydrogenated egg phosphatidylcholine-based liposomes. Int. J. Pharm. 224(1-2):69-79.
77. Ishida, T., Harashima, H., Kiwada, H. (2002). Liposome clearance. Biosci. Rep. 22(2):197-224.
78. Ishida, T., Maeda, R., Ichihara, M., Irimura, K., Kiwada, H. (2003a). Accelerated clearance of PEGylated liposomes in rats after repeated injections. J. Control Release 88(1):35-42.
79. Ishida, T., Masuda, K., Ichikawa, T., Ichihara, M., Irimura, K., Kiwada, H. (2003b). Accelerated clearance of a second injection of PEGylated liposomes in mice. Int. J. Pharm. 255(1-2):167-174.
80. Ishida, T., Ichikawa. T., Ichihara, M., Sadzuka, Y., Kiwada, H. (2004). Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice. J. Control Release 95(3):403-412.
81. Johnstone, S. A., Masin, D., Mayer, L., Bally, M. B. (2001). Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages. Biochim. Biophys. Acta 1513(1):25-37.
82. Kamps, J. A. A. M., Morselt, H. W., Scherphof, G. L. (1999). Uptake of liposomes containing phosphatidylserine by liver cells in vivo and by sinusoidal liver cells in primary culture: in vivo-in vitro differences. Biochem Biophys Res Commun 256(1):57-62.
83. Kinoshita, T., Inoue, K., Okada, M., Akiyama, Y. (1977). Release of phospholipids from liposomal model membrane damaged by antibody and complement. J. Immunol. 119(1):73-76.
84. Kinsky, S. C., Haxby, J. A., Zopf, D. A., Alving, C. R., Kinsky, C. B. (1969). Complement-dependent damage to liposomes prepared from pure lipids and Forssman hapten. Biochemistry 8(10):4149-4158.
85. Klibanov, A. L., Maruyama, K., Torchilin, V. P., Huang, L. (1990). Amphipathic polyethylene-glycols effectively prolong the circulation time of liposomes. FEBS Lett. 268(1):235-237.
86. Koning, G. A., Kamps, J. A. A. M., Scherphof, G. L. (2002). Interference of macrophages with immunotargeting of liposomes. J. Liposome Res. 12(1-2):107-119.
87. Koukourakis, M. I., Koukouraki, S., Giatromanolaki, A., Archimandritis, S. C., Skarlatos, J., Beroukas, K., Bizakis, J. G., Retails, G., Karkavitsas, N., Helidonis, E. S. (1999). Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer. J. Clin. Oncol. 17(11):3512-3521.
88. Kovacsovics, T., Tschopp, J., Kress, A., Isliker, H. (1985). Antibody-independent activation of Cl, the first component of complement, by cardiolipin. J. Immunol. 135(4):2695-2700.
89. Kraus, D., Medof, M. E., Mold, C. (1998). Complementary recognition of alternative pathway activators by decay-accelerating factor and factor H. Infect. Immun. 66(2):399-405.
90. Krieger, M. (1999). Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. Annu. Rev. Biochem. 68:523-558.
91. Krieger, M., Herz, J. (1994). Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63:601-637.
92. Kuhlman, M., Joiner, K., Ezekowitz, R. A. (1989). The human mannose-binding protein functions as an opsonin. J. Exp. Med. 169(5):1733-1745.
93. Kuroki, Y., Honma, T., Chiba, H., Sano, H., Saitoh, M., Ogasawara, Y., Sohma, H., Akino, T. (1997). A novel type of binding specificity to phospholipids for rat mannose-binding proteins isolated from serum and liver. FEBS Lett. 414(2):387-392.
94. Lasic, D. D., Martin, F. J., Gabizon, A., Huang, S. K., Papahadjopoulos, D. (1991). Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta 1070(1):187-192.
95. Laverman, P., Boerman, O. C., Oyen, W. J. G., Corstens, F. H. M., Storm, G. (2001a). In vivo applications of PEG liposomes: unexpected observations. Crit. Rev. Ther. Drug Can. Syst. 18(6):551-566.
96. Laverman, P., Carstens, M. G., Boerman, O. C., Dams, E. T., Oyen, W. J., van Rooijen, N., Corstens, F. H., Storm, G. (2001b). Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J. Pharmacol. Exp. Ther. 298(2):607-612.
97. Lee, N. S., Brewer, H. B. Jr., Osborne, J. C. Jr. (1983). Beta 2-glycoprotein I. Molecular properties of an unusual apolipoprotein, apolipoprotein H. J. Biol. Chem. 258(8):4765-4770.
98. Lee, K. D., Hong, K., Papahadjopoulos, D. (1992a). Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density. Biochim. Biophys. Acta 1103(2):185-197.
99. Lee, K. D., Pitas, R. E., Papahadjopoulos, D. (1992b). Evidence that the scavenger receptor is not involved in the uptake of negatively charged liposomes by cells. Biochim. Biophys. Acta 1111(1):1-6.
100. Leserman, L. D., Weinstein, J. N., Blumenthal, R., Terry, W. D. (1980). Receptor-mediated endocytosis of antibody-opsonized liposomes by tumor cells. Proc. Natl. Acad. Sci. U. S. A. 77(7):4089-4093.
101. Levine, S. J., Walsh, T. J., Martinez, A., Eichacker, P. Q., Lopez-Berestein, G., Natanson, C. (1991). Cardiopulmonary toxicity after liposomal amphotericin B infusion. Ann. Intern. Med. 114(8):664-666.
102. Liu, F., Liu, D. (1996). Serum independent liposome uptake by mouse liver. Biochim. Biophys. Acta 1278(1):5-11.
103. Liu, D., Huang, L., Moore, M. A., Anantharamaiah, G. M., Segrest, J. P. (1990). Interactions of serum proteins with small unilamellar liposomes composed of dioleoylphosphatidylethanolamine and oleic acid: high-density lipoprotein, apolipoprotein A1, and amphipathic peptides stabilize liposomes. Biochemistry 29(15):3637-3643.
104. Liu, D., Liu, F., Song, Y. K. (1995a). Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin. Biochim. Biophys. Acta 1235(1):140-146.
105. Liu, D., Hu, Q., Song, Y. K. (1995b). Liposome clearance from blood: different animal species have different mechanisms. Biochim. Biophys. Acta 1240(2):277-284.
106. Liu, D., Song, Y. K., Liu, F. (1995c). Antibody dependent, complement mediated liver uptake of liposomes containing GM1. Pharm. Res. 12(11):1775-1780.
107. Liu, D., Liu, F., Song, Y. K. (1995d). Monosialoganglioside GM1 shortens the blood circulation time of liposomes in rats. Pharm. Res. 12(4):508-512.
108. Liu, S., Ishida, T., Kiwada, H. (1997). Effect of serum components from different species on destabilizing hydrogenated phosphatidylcholine-based liposomes. Biol. Pharm. Bull. 20(8):874-880.
109. Liu, Q., Kobayashi, K., Furukawa, J., Inagaki, J., Sakairi, N., Iwado, A., Yasuda, T., Koike, T., Voelker, D. R., Matsuura, E. (2002). Omega-carboxyl variants of 7-ketocholesteryl esters are ligands for beta(2)-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages. J. Lipid Res. 43(9):1486-1495.
110. Lougheed, M., Lum, C. M., Ling, W., Suzuki, H., Kodama, T., Steinbrecher, U. (1997). High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II. J. Biol. Chem. 272(20):12938-12944.
111. Lutz, H. U., Stammler, P., Jelezarova, E., Nater, M., Spath, P. J. (1996). High doses of immunoglobulin G attenuate immune aggregate-mediated complement activation by enhancing physiologic cleavage of C3b in C3bn-IgG complexes. Blood 88(1):184-193.
112. Mahley, R. W., Ji, Z. S. (1999). Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40(1):1-16.
113. Malerod, L., Juvet, K., Gjoen, T., Berg, T. (2002). The expression of scavenger receptor class B, type I (SR-BI) and caveolin-1 in parenchymal and nonparenchymal liver cells. Cell Tissue Res. 307(2):173-180.
114. Marjan, J., Xie, Z., Devine, D. V. (1994). Liposome-induced activation of the classical complement pathway does not require immunoglobulin. Biochim. Biophys. Acta 1192(1):35-44.
115. Marjan, J. M., Allen, T. M. (1996). Long circulating liposomes: past, present and future. Biotechnol. Adv. 14(2):151-175.
116. Maruyama, K., Yuda, T., Okamoto, A., Kojima, S., Suginaka, A., Iwatsuru, M. (1992). Prolonged circulation time in vivo of large unilamelar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim. Biophys. Acta 1128(1):44-49.
117. McEvoy, L., Williamson, P., Schlegel, R. A. (1986). Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages. Proc. Natl. Acad. Sci. U. S. A. 83(10):3311-3315.
118. McNeil, H. P., Chesterman, C. N., Krilis, S. A. (1989). Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. Br. J. Haematol. 73(4):506-513.
119. Mendez, A. J., He, J. L., Huang, H. S., Wen, S. R., Hsia, S. L. (1988). Interaction of rabbit lipoproteins and red blood cells with liposomes of egg yolk phospholipids. Lipids 23(10):961-967.
120. Moghimi, S. M., Patel, H. M. (1988). Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes. FEBS Lett. 233(1):143-147.
121. Moghimi, S. M., Patel, H. M. (1989). Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes. Biochim. Biophys. Acta 984(3):384-387.
122. Moghimi, S. M., Muir, I. S., Ilium, L., Davis, S. S., Kolb-Bachofen, V. (1993). Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim. Biophys. Acta 1179(2):157-165.
123. Moghimi, S. M., Szebeni, J. (2003). Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid. Res. 42(6):463-478.
124. Mori, A., Klibanov, A. L., Torchilin, V. P., Huang, L. (1991). Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett. 284(2):263-266.
125. Muller-Eberhard, H. J. (1988). Molecular organization and function of the complement system. Annu. Rev. Biochem. 57:321-347.
126. Murai, M., Aramaki, Y., Tsuchiya, S. (1995). Identification of the serum factor required for liposome-primed activation of mouse peritoneal macrophages. Modified alpha 2-macroglobulin enhances Fc gamma receptor-mediated phagocytosis of opsonized sheep red blood cells. Immunology 86(1):64-70.
127. Nakaya, Y., Schaefer, E. J., Brewer, H. B. Jr. (1980). Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I). Biochem. Biophys. Res. Commun. 95(3):1168-1172.
128. Needham, D., McIntosh, T. J., Lasic, D. D. (1992). Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim. Biophys. Acta 1108(1):40-48.
129. Nishikawa, K., Arai, H., Inoue, K. (1990). Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. J. Biol. Chem. 265(9):5226-5231.
130. Ohta, M., Okada, M., Yamashina, I., Kawasaki, T. (1990). The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein. J. Biol. Chem. 265(4):1980-1984.
131. Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., Redemann, C. (1991). Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. U. S. A. 88(24):11460-11464.
132. Patel, H. M. (1992). Serum opsonins and liposomes: their interaction and opsonophagocytosis. Crit. Rev. Ther. Drug Carr. Syst. 9(1):39-90.
133. Pepys, M. B., Baltz, M. L. (1983). Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv. Immunol. 34:141-212.
134. Polz, E., Kostner, G. M. (1979). The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions. FEBS Lett. 102(1):183-186.
135. Poste, G. (1983). Liposome targeting in vivo-problems and opportunities. Biol. Cell 47(1):19-38.
136. Price, B. E.,Rauch, J., Shia, M. A., Walsh, M. T., Lieberthal, W., Gilligan, H. M., O'Laughlin, T., Koh, J. S., Levine, J. S. (1996). Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner. J. Immunol. 157(5):2201-2208.
137. Price, M. E., Cornelius, R. M., Brash, J. L. (2001). Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma. Biochim. Biophys. Acta 1512(2):191-205.
138. Richards, R. L., Gewurz, H., Osmand, A. P., Alving, C. R. (1977). Interactions of C-reactive protein and complement with liposomes. Proc. Natl. Acad. Sci. U. S. A. 74(12):5672-5676.
139. Richards, R. L., Habbersett, R. C., Scher, I., Janoff, A. S., Schieren, H. P., Mayer, L. D., Cullis, P. R., Alving, C. R. (1986). Influence of vesicle size on complement-dependent immune damage to liposomes. Biochim. Biophys. Acta 855(2):223-230.
140. Rigotti, A., Acton, S. L., Krieger, M. (1995). The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J. Biol. Chem. 270(27):16221-16224.
141. Rigotti, A., Miettinen, H. E., Krieger, M. (2003). The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr. Rev. 24(3):357-387.
142. Ringden, O., Andstrom, E., Remberger, M., Svahn, B. M., Tollemar, J. (1994). Allergic reactions and other rare side-effects of liposomal amphotericin. Lancet 344(8930):1156-1157.
143. Roerdink, F., Wassef, N. M., Richardson, E. C., Alving, C. R. (1983). Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement. Biochim. Biophys. Acta 734(1):33-39.
144. Rossi, J. D., Wallace, B. A. (1983). Binding of fibronectin to phospholipid vesicles. J. Biol. Chem. 258(5):3327-3331.
145. Salmon, J. E., Girardi, G. (2004). The role of complement in the antiphospholipid syndrome. Curr. Dir. Autoimmun. 7:133-148.
146. Salter, A. M., Brindley, D. N. (1988). The biochemistry of lipoproteins. J. Inherit. Metab. Dis. 11 suppl 1:4-17.
147. Sambrano, G. R., Steinberg, D. (1995). Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidyIserine. Proc. Natl. Acad. Sci. U. S. A. 92(5):1396-1400.
148. Savay, S., Szebeni, J., Baranyi, L., Alving, C. R. (2002). Potentiation of liposome-induced complement activation by surface-bound albumin. Biochim. Biophys. Acta 1559(1):79-86.
149. Scherphof, G. L., Morselt, H., Allen, T. M. (1994). Intrahepatic distribution of long-circulating liposomes containing poly(ethylene glycol)-distearoylphosphatidylethanolamine. J. Liposome Res. 4(1):213-228.
150. Scherphof, G. L., Kamps, J. A. A. M. (2001). The role of hepatocytes in the clearance of liposomes from the blood circulation. Prog. Lipid Res. 40(3):149-166.
151. Schrett, J., Liszka, K., Varro, R., Gergely, J. (1980). Interaction of targeted liposomes with human peripheral mononuclear blood cells and lymphocytes of chronic lymphoid leukaemic patients. Allerg. Immunol. (Leipz) 26(3):243-252.
152. Schroit, A. J., Tanaka, Y., Madsen, J., Fidler, I. J. (1984). The recognition of red blood cells by macrophages: role of phosphatidylserine and possible implications of membrane phospholipid asymmetry. Biol. Cell 51(2):227-238.
153. Schwalbe, R. A., Dahlback, B., Nelsestuen, G. L. (1990). Independent association of serum amyloid P component, protein S, and complement C4b with complement C4b-binding protein and subsequent association of the complex with membranes. J. Biol. Chem. 265(35):21749-21757.
154. Scieszka, J. F., Cho, M. J. (1988). Cellular uptake of a fluid-phase marker by human neutrophils from solutions and liposomes. Pharm. Res. 5(6):352-358.
155. Scieszka, J. F., Maggiora, L. L., Wright, S. D., Cho, M. J. (1991). Role of complements C3 and C5 in the phagocytosis of liposomes by human neutrophils. Pharm. Res. 8(1):65-69.
156. Seifen, P. S., Kazatchkine, M. D. (1987). Generation of complement anaphylatoxins and C5b-9 by crystalline cholesterol oxidation derivatives depends on hydroxyl group number and position. Mol. Immunol. 24(12):1303-1308.
157. Senior, J. H. (1987). Fate and behavior of liposomes in vivo: a review of controlling factors. Crit. Rev. Ther. Drug Can. Syst. 3(2):123-193.
158. Senior, J., Waters, J. A., Gregoriadis, G. (1986). Antibody-coated liposomes. The role of non-specific antibody adsorption. FEBS Lett. 196(1):54-58.
159. Senior, J., Delgado, C., Fisher, D., Tilcock, C., Gregoriadis, G. (1991). Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys. Acta 1062(1):77-82.
160. Sessa, G., Weissmann, G. (1970). Incorporation of lysozyme into liposomes. A model for structure-linked latency. J. Biol. Chem. 245(13):3295-3301.
161. Sheng, Y., Sali, A., Herzog, H., Lahnstein, J., Krilis, S. A. (1996). Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J. Immunol. 157(8):3744-3751.
162. Shin, M. L., Paznekas, W. A., Mayer, M. M. (1978). On the mechanism of membrane damage by complement: the effect of length and unsaturation of the acyl chains in liposomal bilayers and the effect of cholesterol concentration in sheep erythrocyte and liposomal membranes. J. Immunol. 120(6):1996-2002.
163. Shiratsuchi, A., Kawasaki, Y., Ikemoto, M., Arai, H., Nakanishi, Y. (1999). Role of class B scavenger receptor type I in phagocytosis of apoptotic
164. Skubitz, K. M., Skubitz, A. P. (1998). Mechanism of transient dyspnea induced by pegylated-liposomal doxorubicin (Doxil). Anti-cancer Drugs 9(1):45-50.
165. Steel, D. M., Whitehead, A. S. (1994). The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 15(2):81-88.
166. Szebeni, J. (1998). The interaction of liposomes with the complement system. Crit. Rev. Ther. Drug Carr. Syst. 15(1):57-88.
167. Szebeni, J., Wassef, N. M., Rudolph, A. S., Alving, C. R. (1996). Complement activation in human serum by liposome-encapsulated hemoglobin: the role of natural anti-phospholipid antibodies. Biochim. Biophys. Acta 1285(2):127-130.
168. Szebeni, J., Wassef, N. M., Hartman, K. R., Rudolph, A. S., Alving, C. R. (1997). Complement activation in vitro by the red cell substitute, liposome-encapsulated hemoglobin: mechanism of activation and inhibition by soluble complement receptor type 1. Transfusion 37(2):150-159.
169. Szebeni, J., Fontana, J. L., Wassef, N. M., Mongan, P. D., Morse, D. S., Dobbins, D. E., Stahl, G. L., Bunger, R., Alving, C. R. (1999). Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody. Circulation 99(17):2302-2309.
170. Szebeni, J., Baranyi, L., Savay, S., Bodo, M., Morse, D. S., Basta, M., Stahl, G. L., Bunger, R., Alving, C. R. (2000). Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction. Am. J. Physiol., Heart Circ. Physiol. 279(3):H1319-H1328.
171. Szebeni, J., Baranyi, L., Savay, S., Milosevits, J., Bunger, R., Laverman, P., Metselaar, J. M., Storm, G., Chanan-Khan, A., Liebes, L., Muggia, F. M., Cohen, R., Barenholz, Y., Alving, C. R. (2002). Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies. J. Liposome Res. 12(1-2):165-172.
172. Szebeni, J., Baranyi, L., Savay, S., Milosevits, J., Bodo, M., Bunger, R., Alving, C. R. (2003). The interaction of liposomes with the complement system: in vitro and in vivo assays. Methods Enzymol. 373:136-154.
173. Temel, R. E., Walzem, R. L., Banka, C. L., Williams, D. L. (2002). Apolipoprotein A-I is necessary for the in vivo formation of high density lipoprotein competent for scavenger receptor BI-mediated cholesteryl ester-selective uptake. J. Biol. Chem. 277(29):26565-26572.
174. Terpstra, V., van Amersfoort, E. S., van Velzen, A. G., Kuiper, J., van Berkel, T. J. (2000). Hepatic and extrahepatic scavenger receptors: function in relation to disease. Arterioscler. Thromb. Vasc. Biol. 20(8):1860-1872.
175. Thiel, S. (1992). Mannan-binding protein, a complement activating animal lectin. Immunopharmacology 24(2):91-99.
176. Thuahnai, S. T., Lund-Katz, S., Williams, D. L., Phillips, M. C. (2001). Scavenger receptor class B, type I-mediated uptake of various lipids into cells. Influence of the nature of the donor particle interaction with the receptor. J. Biol. Chem. 276(47):43801-43808.
177. Torchilin, V. P., Omelyanenko, V. G., Papisov, M. I., Bogdanov, A. A. Jr., Trubetskoy, V. S., Herron, J. N., Gentry, C. A. (1994). Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim. Biophys. Acta 1195(1):11-20.
178. Urban, S., Zieseniss, S., Werder, M., Hauser, H., Budzinski, R., Engelmann, B. (2000). Scavenger receptor B1 transfers major lipoprotein- associated phospholipids into the cells. J. Biol. Chem. 275(43):33409-33415.
179. Uziely, B., Jeffers, S., Isacson, R., Kutsch, K., Wei-Tsao, D., Yehoshua, Z., Libson, E., Muggia, F. M., Gabizon, A. (1995). Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. J. Clin. Oncol. 13(7):1777-1785.
180. Van Velzen, A. G., Da Silva, R. P., Gordon, S., Van Berkel, T. J. (1997). Characterization of a receptor for oxidized low-density lipoproteins on rat Kupffer cells: similarity to macrosialin. Biochem. J. 322(Pt 2):411-415.
181. Vazquez-Mellado, J., Llorente, L., Richaud-Patin, Y., Arcon-Segovia, D. (1994). Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects. J. Autoimmun. 7(3):335-348.
182. Vert, M., Domurado, D. (2000). Poly(ethylene glycol): protein-repulsive or albumin-compatible? J. Biomater. Sci., Polym. Ed. 11(12):1307-1317.
183. Volanakis, J. E., Kaplan, M. H. (1974). Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q. J. Immunol. 113(1):9-17.
184. Volanakis, J. E., Narkates, A. J. (1981). Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement. J. Immunol. 126(5):1820-1825.
185. Wassef, N. M., Alving, C. R. (1993). Complement-dependent phagocytosis of liposomes. Chem. Phys. Lipids 64(1-3):239-248.
186. Wassef, N. M., Johnson, S. H., Graeber, G. M., Swartz, G. M. Jr., Schultz, C. L., Hailey, J. R., Johnson, A. J., Taylor, D. G., Ridgway, R. L., Alving, C. R. (1989). Anaphylactoid reactions mediated by autoantibodies to cholesterol in miniature pigs. J. Immunol. 143(9):2990-2995.
187. Weissmann, G., Bloomgarden, D., Kaplan, R., Cohen, C., Hoffstein, S., Collins, T., Gotlieb, A., Nagle, D. (1975). A general method for the introduction of enzymes, by means of immunoglobulin-coated liposomes, into lysosomes of deficient cells. Proc. Natl. Acad. Sci. U. S. A. 72(1):88-92.
188. Woodle, M. C. (1998). Controlling liposome blood clearance by surface-grafted polymers. Adv. Drug Deliv. Rev. 32(1-2):139-152.
189. Woodle, M. C., Lasic, D. D. (1992). Sterically stabilized liposomes. Biochim. Biophys. Acta 1113(2):171-199.
190. Wurm, H. (1984). Beta 2-glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. Int. J. Biochem. 16(5):511-515.
191. Yamada, K. M., Olden, K. (1978). Fibronectins-adhesive glycoproteins of cell surface and blood. Nature 275(5677):179-184.
192. Yan, X., Morselt, H. W. M., Scherphof, G. L., Poelstra, K., Kamps, J. A. A. M. (2004). The role of beta 2-glycoprotein I in liposome-heaptocyte interaction. Biochim. Biophys. Acta 1667(2):208-214.
193. Yan, X., Poelstra, K., Scherphof, G. L., Kamps, J. A. A. M. (2004). A role for scavenger receptor B-I in selective transfer of rhodamine-PE from liposomes to cells. Biochem. Biophys. Res. Commun 325:908-914.
194. Ying, S. C., Gewurz, A. T., Jiang, H., Gewurz, H. (1993). Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q. J. Immunol. 150(1):169-176.
195. Yokoyama, S., Tajima, S., Yamamoto, A. (1984). Association of apolipoprotein A-II with egg phosphatidylcholine unilamellar vesicles. J. Biochem. (Tokyo) 96(3):871-880.
196. Young, B., Gleeson, M., Cripps, A. W. (1991). C-reactive protein: a critical review. Pathology 23(2):118-124.